✦ LIBER ✦

Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer

✍ Scribed by Qingyu Zhou; Alex Sparreboom; Eng-Huat Tan; Yin-Bun Cheung; Ann Lee; Donald Poon; Edmund J. D. Lee; Balram Chowbay

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Integrated pharmacogenetic prediction of

✍ Han, Ji-Youn; Lim, Hyeong-Seok; Park, Yong Hoon; Lee, Sung Young; Lee, Jin Soo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Pharmacokinetic and pharmacogenetic dete

✍ Rouits, E; Charasson, V; Pétain, A; Boisdron-Celle, M; Delord, J-P; Fonck, M; La 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 149 KB

Irinotecan in the treatment of elderly p

✍ Javier Sastre; Javier Puente; Jose A. García-Saenz; Eduardo Díaz-Rubio 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 114 KB

447 POSTER The impact of UGT1A1*28 and U

✍ B. Chowbay; S.J. Srinivasa Jada Rao; B.C. Goh Boon Cher; R. Robert Lim; W.T. Lim 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Pharmacogenetic profiling of CD133 is as

✍ Pohl, A; El-Khoueiry, A; Yang, D; Zhang, W; Lurje, G; Ning, Y; Winder, T; Hu-Lie 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 401 KB

Point mutations in the topoisomerase I g

✍ Tsurutani, Junji; Nitta, Takashi; Hirashima, Tomonori; Komiya, Takefumi; Uejima, 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 189 KB